Michael V. Quinn
Vertrieb & Marketing bei JDS Therapeutics LLC
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael S. Satow | M | - |
JDS Therapeutics LLC
 JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | 13 Jahre |
| Phillip M. Satow | M | 81 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | 13 Jahre |
| James R. Komorowski | M | - |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Frederic Poses | M | 80 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Joseph R. Gregory | M | 70 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Bob Johnston | M | 87 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Michael Koby | M | 51 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Richard Scott Pechter | M | 78 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| Martin G. Friedman | M | - |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Gregg Bresner | M | 56 |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | 4 Jahre |
| Jed Rosenbaum | M | - |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
| David T. Simm | M | - |
JDS Therapeutics LLC
JDS Therapeutics LLC Pharmaceuticals: MajorHealth Technology JDS Therapeutics LLC develops and commercializes healthcare products to physicians, healthcare-delivery networks, and other healthcare professionals. Its products include Relizen, Serenol, and pipeline. The firms pipeline drugs include treatment for polycystic ovary syndrome (PCOS), an oral treatment for type 2 diabetes leveraging a novel mechanism of action with established safety, and a novel insulin. The company was founded by Phillip M. Satow and Michael S. Satow in 2011 and is headquartered in Purchase, NY. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 12 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Michael V. Quinn
- Persönliches Netzwerk